Literature DB >> 5046626

The polymorphic acetylation of sulphapyridine in man.

H Schröder, D A Evans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5046626      PMCID: PMC1469041          DOI: 10.1136/jmg.9.2.168

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  5 in total

1.  HUMAN ACETYLATION POLYMORPHISM.

Authors:  D A EVANS; T A WHITE
Journal:  J Lab Clin Med       Date:  1964-03

2.  Genetic control of isoniazid metabolism in man.

Authors:  D A EVANS; K A MANLEY; V A McKUSICK
Journal:  Br Med J       Date:  1960-08-13

3.  Metabolic studies on azulfidine, azudimidine and one analogue.

Authors:  L E BOTTIGER; H MOLLERBERG
Journal:  Acta Med Scand       Date:  1959-11-18

4.  An improved and simplified method of detecting the acetylator phenotype.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1969-12       Impact factor: 6.318

5.  The polymorphic acetylation of dapsone in man.

Authors:  R Gelber; J H Peters; G R Gordon; A J Glazko; L Levy
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

  5 in total
  22 in total

1.  Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole.

Authors:  T B Vree; Y A Hekster; A M Baars; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

2.  Salicylazosulfapyridine in inflammatory bowel disease.

Authors:  K M Das; I Sternlieb
Journal:  Am J Dig Dis       Date:  1975-10

3.  The relationship between the acetylator and the sparteine hydroxylation polymorphisms.

Authors:  D Harmer; D A Evans; L C Eze; M Jolly; E J Whibley
Journal:  J Med Genet       Date:  1986-04       Impact factor: 6.318

Review 4.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

Review 5.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

6.  Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.

Authors:  T B Vree; Y A Hekster; J E Damsma; E van der Kleijn; W J O'Reilly
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

7.  Sulphasalazine and male infertility: reversibility and possible mechanism.

Authors:  S Toovey; E Hudson; W F Hendry; A J Levi
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

8.  Effects of salbutamol on the absorption and disposition of sulphamethoxazole in adult volunteers.

Authors:  G I Adebayo; T O Ogundipe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

9.  The association of the slow acetylator phenotype with bladder cancer.

Authors:  D A Evans; L C Eze; E J Whibley
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

10.  Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase.

Authors:  D J Hearse; W W Weber
Journal:  Biochem J       Date:  1973-03       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.